Brief: Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader With Extensive Antiviral Development Experience, As Chief Executive Officer
03/06/2026 12:04
BRIEF-Cocrystal Pharma Appoints James Sapirstein, Biopharma Industry Leader With Extensive Antiviral Development Experience, As Chief Executive Officer June 3 (Reuters) - Cocrystal Pharma Inc COCP.O:
COCRYSTAL PHARMA APPOINTS JAMES SAPIRSTEIN, BIOPHARMA INDUSTRY LEADER WITH EXTENSIVE ANTIVIRAL DEVELOPMENT EXPERIENCE, AS CHIEF EXECUTIVE OFFICER
COCRYSTAL PHARMA - PLANS TO APPOINT JAMES SAPIRSTEIN TO BOARD OF DIRECTORS
COCRYSTAL PHARMA - SAM LEE TO TRANSITION TO CHIEF SCIENTIFIC OFFICER; JIM MARTIN TO CONTINUE AS CFO
Source text: ID:nGNX8R11KG
Further company coverage: COCP.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway